Human placental aldehyde dehydrogenase. Subcellular distribution and properties

Area of Science:

• Biochemistry
• Human placental physiology
• Enzymology

Background:

• NAD-dependent aldehyde dehydrogenases (ALDHs) are crucial for metabolizing aldehydes.
• Understanding ALDH localization in the human placenta is vital for assessing fetal exposure to maternal ethanol metabolites.
• Previous studies have not fully elucidated the specific placental localization and characteristics of ALDH isozymes.

Purpose of the Study:

• To investigate the subcellular localization of NAD-dependent aldehyde dehydrogenases in human term placentae.
• To characterize the kinetic properties and inhibition patterns of placental ALDH isozymes.

Main Methods:

• Subcellular fractionation of human term placentae.
• Isoelectric focusing on polyacrylamide gels to separate ALDH isozymes.
• Enzyme activity assays and kinetic analysis (Km) for acetaldehyde.
• Disulfiram inhibition studies.

Main Results:

• Two distinct ALDH isozymes (I and II) were identified in placental extracts.
• Approximately 80% of total ALDH activity was found in the cytosolic fraction, with about 10% in the mitochondrial fraction.
• Aldehyde dehydrogenase II, predominant in the cytosol, exhibited a high Km (9 mmol/l) for acetaldehyde and was strongly inhibited by disulfiram.
• The cytosolic enzyme's activity was deemed too slow to prevent placental passage of typical maternal blood acetaldehyde levels (<1 mumol/l).

Conclusions:

• The human placenta's cytosol is the primary site for acetaldehyde oxidation, mainly via aldehyde dehydrogenase II.
• The kinetic properties of placental aldehyde dehydrogenase II suggest it is not sufficiently rapid to fully prevent fetal exposure to acetaldehyde derived from maternal ethanol consumption.
• Further research may be needed to explore alternative placental detoxification mechanisms or the implications of fetal acetaldehyde exposure.